Richard Klausner resigned from the Gates Foundation, saying move was unrelated to Congressional investigation of NCI contract to Harvard University during Klausner’s tenure as NCI director.
FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.
Three cancer centers joined the Multiple Myeloma Research Consortium.
